Morbidity control of schistosomiasis in China

被引:8
作者
Jiang, QW
Wang, LY
Guo, JG
Chen, MG
Zhou, XN
Engels, D
机构
[1] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China
[2] Minist Hlth, Bur Dis Control, Beijing, Peoples R China
[3] Acad Prevent Med, Inst Parasit Dis, Shanghai, Peoples R China
[4] Jiangsu Prov Inst Parasit Dis, Wuxi, Peoples R China
[5] WHO, Geneva, Switzerland
关键词
morbidity control; Schistosoma japonicum; case study; chemotherapy; China;
D O I
暂无
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
After reviewing the schistosomiasis control program in China with focusing on the socio-economic impact on schistosomiasis endemicity, we introduce the promotion process of morbidity control strategy undertaken before and during the World Bank Loan Project (WBLP) on Schistosomiasis Control. We analyzed the data derived from case study of morbidity control for schistosomiasis, and evaluated the efficacy of chemotherapy. It is suggested that appropriate drug treatment declines worm burden and the intensity of infection as well as prevalence, but chemotherapy alone can hardly reduce the transmission because zoonotic Schistosoma japonicum infection has a great impact on the transmission of the disease. Therefore, the strategies in different (high, medium, and low) transmission areas during the maintenance stage were put forward in consideration of challenges in national control program in the future. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:115 / 125
页数:11
相关论文
共 8 条
[1]  
[Anonymous], 1993, WHO TECHN REP SER, V830
[2]  
CHEN M, 1990, CHIN J SCHISTO CONTR, V2, P28
[3]  
CHEN MG, 1989, TROP MED PARASITOL, V40, P174
[4]  
GAO SF, 1993, EPIDEMIOLOGICAL SITU, P16
[5]  
WANG HZ, 1989, CHIN J SCHISTOSOMIAS, V1, P1
[6]  
Wang L.Y., 2000, ZHONNGUO XUEXICHONGB, V06, P321
[7]  
YUAN HC, 1992, ABSTR INT S SCHISTOS, P30
[8]  
ZHENG J, 1992, ABSTR INT S SCHIST P, P1